Masaaki Higashihara
Sagamihara, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Phase II clinical trial of personalized VCD-VTD sequential therapy using the Vulnerable Elders Survey-13 (VES-13) for transplant-ineligible patients with newly diagnosed multiple myeloma.
Journal: Annals of hematology
Published: April 10, 2021
The clinical outcomes of chronic myeloid leukemia patients harboring alternatively spliced BCR-ABL variants.
Journal: Hematology (Amsterdam, Netherlands)
Published: August 21, 2018
CD30 Characterizes Polylobated Lymphocytes and Disease Progression in HTLV-1-Infected Individuals.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 23, 2018
Dasatinib-associated reversible demyelinating peripheral polyneuropathy in a case of chronic myeloid leukemia.
Journal: International journal of hematology
Published: May 23, 2017
KIF5A transports collagen vesicles of myofibroblasts during pleural fibrosis.
Journal: Scientific reports
Published: October 19, 2016
CD109, a negative regulator of TGF-β signaling, is a putative risk marker in diffuse large B-cell lymphoma.
Journal: International journal of hematology
Published: October 04, 2016
CD30 Induces Heat Shock Protein 90 and Signal Integration in Classic Hodgkin Lymphoma Cells.
Journal: The American journal of pathology
Published: March 06, 2016
Multiple allogeneic progenitors in combination function as a unit to support early transient hematopoiesis in transplantation.
Journal: The Journal of experimental medicine
Published: September 16, 2015
Efficacy and safety of rituximab in Japanese patients with relapsed chronic immune thrombocytopenia refractory to conventional therapy.
Journal: International journal of hematology
Published: September 02, 2015
Pre-Transplantation Blockade of TNF-α-Mediated Oxygen Species Accumulation Protects Hematopoietic Stem Cells.
Journal: Stem cells (Dayton, Ohio)
Published: August 27, 2015
High expression of REV7 is an independent prognostic indicator in patients with diffuse large B-cell lymphoma treated with rituximab.
Journal: International journal of hematology
Published: August 25, 2015
Immature platelet fraction measurement is influenced by platelet size and is a useful parameter for discrimination of macrothrombocytopenia.
Journal: Hematology (Amsterdam, Netherlands)
Published: June 03, 2015
Last Updated: 09/26/2026